NASDAQ Composite opens in less than sixteen hours and Arena Pharmaceuticals’s premarket value is already 1.67% down.
The last session, NASDAQ Composite ended with Arena Pharmaceuticals rising 1.71% to $78.31. NASDAQ Composite rose 0.43% to $13,128.95, following last session’s upward trend on what was a somewhat positive trend trading session.
Arena Pharmaceuticals’s last close was $76.99, 15.17% under its 52-week high of $90.19.
Arena Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.
Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 3.59%, 0.54%, and 0.41%, respectively.
Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 5.86%, 4.01%, and 3.51%, respectively.